Mobia Medical, Inc.(MOBI)
$13.03+0.42 (+3.33%)
MOBI
Mobia Medical, Inc. financials statements
$13.03
At close:+0.42 (+3.33%)
Want to see MOBI full AI Analyst Report?
Mobia Medical, Inc. (MOBI) Ratios
11 Followers
Mobia Medical, Inc. Ratios
MOBI's free cash flow for Q3 2026 was $-12.98M. For the 2026 fiscal year, MOBI's free cash flow was decreased by $-58.00K and operating cash flow was $-12.92M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 |
|---|---|---|
| Liquidity Ratios | ||
| Current Ratio | 4.54 | ― |
| Quick Ratio | 4.01 | ― |
| Cash Ratio | 3.29 | ― |
| Solvency Ratio | -0.23 | ― |
| Operating Cash Flow Ratio | -4.48 | ― |
| Short-Term Operating Cash Flow Coverage | 0.00 | ― |
| Net Current Asset Value | $ -152.57M | ― |
| Leverage Ratios | ||
| Debt-to-Assets Ratio | 0.18 | ― |
| Debt-to-Equity Ratio | -0.06 | ― |
| Debt-to-Capital Ratio | -0.06 | ― |
| Long-Term Debt-to-Capital Ratio | -0.05 | ― |
| Financial Leverage Ratio | -0.32 | ― |
| Debt Service Coverage Ratio | -46.91 | ― |
| Interest Coverage Ratio | -47.93 | ― |
| Debt to Market Cap | 0.01 | ― |
| Interest Debt Per Share | 0.28 | ― |
| Net Debt to EBITDA | 0.55 | ― |
| Profitability Margins | ||
| Gross Profit Margin | 81.07% | ― |
| EBIT Margin | -142.08% | ― |
| EBITDA Margin | -141.61% | ― |
| Operating Profit Margin | -144.71% | ― |
| Pretax Profit Margin | -145.10% | ― |
| Net Profit Margin | -145.12% | ― |
| Continuous Operations Profit Margin | -145.12% | ― |
| Net Income Per EBT | 100.01% | ― |
| EBT Per EBIT | 100.27% | ― |
| Return on Assets (ROA) | -96.57% | ― |
| Return on Equity (ROE) | 30.84% | ― |
| Return on Capital Employed (ROCE) | -122.21% | ― |
| Return on Invested Capital (ROIC) | -121.06% | ― |
| Return on Tangible Assets | -96.57% | ― |
| Earnings Yield | -9.37% | ― |
| Efficiency Ratios | ||
| Receivables Turnover | 7.22 | ― |
| Payables Turnover | 2.73 | ― |
| Inventory Turnover | 1.11 | ― |
| Fixed Asset Turnover | 18.44 | ― |
| Asset Turnover | 0.67 | ― |
| Working Capital Turnover Ratio | 1.22 | ― |
| Cash Conversion Cycle | 245.11 | ― |
| Days of Sales Outstanding | 50.52 | ― |
| Days of Inventory Outstanding | 328.34 | ― |
| Days of Payables Outstanding | 133.76 | ― |
| Operating Cycle | 378.87 | ― |
| Cash Flow Ratios | ||
| Operating Cash Flow Per Share | -1.38 | ― |
| Free Cash Flow Per Share | -1.39 | ― |
| Dividend Paid and CapEx Coverage Ratio | -125.39 | ― |
| Capital Expenditure Coverage Ratio | -125.39 | ― |
| Operating Cash Flow Coverage Ratio | -5.42 | ― |
| Operating Cash Flow to Sales Ratio | -1.43 | ― |
| Free Cash Flow Yield | -9.28% | ― |
| Valuation Ratios | ||
| Price-to-Earnings (P/E) Ratio | -10.64 | ― |
| Price-to-Sales (P/S) Ratio | 15.49 | ― |
| Price-to-Book (P/B) Ratio | -3.29 | ― |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.77 | ― |
| Price-to-Operating Cash Flow Ratio | -10.86 | ― |
| Price-to-Earnings Growth (PEG) Ratio | -0.12 | ― |
| Enterprise Value Multiple | -10.38 | ― |
| Enterprise Value | 471.13M | ― |
| EV to EBITDA | -10.38 | ― |
| EV to Sales | 14.70 | ― |
| EV to Free Cash Flow | -10.23 | ― |
| EV to Operating Cash Flow | -10.31 | ― |
| Tangible Book Value Per Share | -4.56 | ― |
| Shareholders’ Equity Per Share | -4.56 | ― |
| Tax and Other Ratios | ||
| Effective Tax Rate | -0.00 | ― |
| Revenue Per Share | 0.97 | ― |
| Net Income Per Share | -1.41 | ― |
| Tax Burden | 1.00 | ― |
| Interest Burden | 1.02 | ― |
| Research & Development to Revenue | 0.20 | ― |
| SG&A to Revenue | 2.05 | ― |
| Stock-Based Compensation to Revenue | 0.05 | ― |
| Income Quality | 0.98 | ― |
Currency in USD

